BNP Paribas Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$508K Buy
62,453
+60,823
+3,731% +$551K ﹤0.01% 1249
2025
Q4
$11K Buy
1,630
+344
+27% +$2.59K ﹤0.01% 2126
2025
Q3
$11K Hold
1,286
﹤0.01% 1608
2025
Q2
$8K Buy
+1,286
New +$8.52K ﹤0.01% 1856
2021
Q4
Sell
-1,228
Closed -$255K 940
2021
Q3
$255K Sell
1,228
-899
-42% -$198K ﹤0.01% 851
2021
Q2
$452K Buy
+2,127
New +$390K ﹤0.01% 821
2016
Q2
Sell
-5,652
Closed -$583K 1102
2016
Q1
$583K Sell
5,652
-48,697
-90% -$5.22M ﹤0.01% 898
2015
Q4
$9.12M Sell
54,349
-6,507
-11% -$1M 0.08% 321
2015
Q3
$8.61M Sell
60,856
-26,703
-30% -$5.99M 0.08% 335
2015
Q2
$19.5M Sell
87,559
-15,681
-15% -$2.76M 0.16% 182
2015
Q1
$17.1M Sell
103,240
-86,734
-46% -$14.1M 0.13% 227
2014
Q4
$22.5M Sell
189,974
-2,040
-1% -$213K 0.18% 161
2014
Q3
$16M Buy
192,014
+13,342
+7% +$1.21M 0.13% 208
2014
Q2
$16.5M Buy
178,672
+71,226
+66% +$6.26M 0.13% 208
2014
Q1
$9.73M Buy
107,446
+49,164
+84% +$5.49M 0.07% 289
2013
Q4
$5.97M Buy
+58,282
New +$4.12M 0.04% 362

Other funds holding NVAX

BNP Paribas Asset Management's NVAX Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Novavax (NVAX) stake by 3,731% in Q1 2026, buying an estimated $551K and bringing the position to 62,453 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

BNP Paribas Asset Management first reported a position in NVAX in Q4 2013 and has held it in 16 quarters since. The position peaked at $22.5M in Q4 2014. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • BNP Paribas Asset Management held 62,453 shares of Novavax worth $508K as of Q1 2026.
  • BNP Paribas Asset Management bought 60,823 Novavax shares in Q1 2026, an estimated $551K.
  • Novavax made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1249 holding.
  • BNP Paribas Asset Management first reported a position in Novavax in Q4 2013 and has held it in 16 quarters since.
  • BNP Paribas Asset Management's Novavax position peaked at $22.5M in Q4 2014.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.